Fayez Sarofim's portfolio
In the Q2 2026 13F, filed August 17, 2026, Fayez Sarofim & Co reported 300 US stock positions worth $42.5B. The largest was Apple (AAPL) at 9.5% of the portfolio. New positions: AstraZeneca (AZN), TotalEnergies (TTE) and Boeing (BA). Added to: Apple (AAPL) and Microsoft (MSFT). The Q3 2026 13F is due by November 14, 2026.
What changed in Q2 2026
Compared with the previous 13F. Values are as reported at quarter end. How to read a 13F.
New positions
- AstraZenecaAZN$34M
- TotalEnergiesTTE$8M
- BoeingBA$326,437
- Hewlett Packard EnterpriseHPE$314,868
- FedExFDX$313,130
- Axon EnterpriseAXON$280,305
- CitigroupC$255,427
- CenterPoint EnergyCNP$253,891
- Crane NXTCXT$240,401
- U.S. BancorpUSB$226,077
Added to
- AppleAAPL$4.1B
- MicrosoftMSFT$3.1B
- AlphabetGOOG$2.8B
- NVIDIANVDA$2.0B
- Amazon.comAMZN$2.0B
- Philip Morris InternationalPM$2.0B
- Meta PlatformsMETA$1.2B
- Coca-ColaKO$1.2B
- JPMorgan Chase & CoJPM$1.1B
- ChevronCVX$1.0B
Trimmed
- Taiwan Semiconductor ManufacturingTSM$1.2B
- Exxon MobilXOM$1.1B
- VisaV$1.0B
- Texas InstrumentsTXN$871M
- UnitedHealth GroupUNH$655M
- Eaton CorporationETN$632M
- MastercardMA$617M
- BlackRockBLK$600M
- Enterprise Products PartnersEPD$588M
- ProgressivePGR$524M
Sold out
None this quarter.
Holdings
300 US-listed positions in the Q2 2026 13F, largest first (top 50 shown; all of them in Investingly).
| Stock | % of portfolio | Value | Shares | Last quarter |
|---|---|---|---|---|
| AppleAAPL | 9.54% | $4.1B | 14,030,274 | Added |
| MicrosoftMSFT | 7.25% | $3.1B | 8,269,855 | Added |
| AlphabetGOOG | 6.51% | $2.8B | 7,841,228 | Added |
| NVIDIANVDA | 4.72% | $2.0B | 10,039,246 | Added |
| Amazon.comAMZN | 4.67% | $2.0B | 8,342,808 | Added |
| Philip Morris InternationalPM | 4.66% | $2.0B | 10,966,757 | Added |
| Meta PlatformsMETA | 2.93% | $1.2B | 2,213,318 | Added |
| Coca-ColaKO | 2.92% | $1.2B | 15,272,831 | Added |
| Taiwan Semiconductor ManufacturingTSM | 2.85% | $1.2B | 2,543,520 | Trimmed |
| Asml Holding Nv-Ny Reg Shs | 2.74% | $1.2B | 586,367 | Held |
| Exxon MobilXOM | 2.51% | $1.1B | 7,817,161 | Trimmed |
| JPMorgan Chase & CoJPM | 2.47% | $1.1B | 3,214,618 | Added |
| ChevronCVX | 2.46% | $1.0B | 6,316,069 | Added |
| VisaV | 2.40% | $1.0B | 2,969,149 | Trimmed |
| Texas InstrumentsTXN | 2.05% | $871M | 2,921,621 | Trimmed |
| McDonald’sMCD | 1.75% | $746M | 2,760,907 | Added |
| AbbVieABBV | 1.70% | $724M | 2,876,785 | Added |
| UnitedHealth GroupUNH | 1.54% | $655M | 1,575,300 | Trimmed |
| Eaton CorporationETN | 1.49% | $632M | 1,483,063 | Trimmed |
| S&P GlobalSPGI | 1.47% | $625M | 1,533,744 | Added |
| MastercardMA | 1.45% | $617M | 1,202,173 | Trimmed |
| BlackRockBLK | 1.41% | $600M | 623,951 | Trimmed |
| Enterprise Products PartnersEPD | 1.38% | $588M | 15,998,982 | Trimmed |
| BroadcomAVGO | 1.26% | $535M | 1,416,634 | Added |
| ProgressivePGR | 1.23% | $524M | 2,399,296 | Trimmed |
| Eli Lilly and CompanyLLY | 1.20% | $511M | 425,688 | Added |
| BlackstoneBX | 1.12% | $476M | 4,042,389 | Added |
| T. Rowe PriceTROW | 1.05% | $446M | 3,923,459 | Trimmed |
| Procter & GamblePG | 0.90% | $383M | 2,614,910 | Trimmed |
| Intuitive SurgicalISRG | 0.88% | $373M | 938,643 | Trimmed |
| Berkshire Hathaway Inc-Cl ABRK/A | 0.86% | $368M | 491 | Added |
| Canadian Pacific Kansas CityCP | 0.84% | $356M | 4,104,463 | Trimmed |
| ChubbCB | 0.81% | $346M | 1,014,340 | Trimmed |
| Berkshire Hathaway Inc-Cl BBRK/B | 0.80% | $339M | 677,492 | Trimmed |
| Morgan StanleyMS | 0.77% | $329M | 1,573,250 | Trimmed |
| Marriott InternationalMAR | 0.72% | $307M | 827,642 | Trimmed |
| Abbott LaboratoriesABT | 0.70% | $297M | 3,278,314 | Trimmed |
| Altria GroupMO | 0.69% | $295M | 4,106,343 | Trimmed |
| Automatic Data ProcessingADP | 0.69% | $294M | 1,314,544 | Trimmed |
| Home DepotHD | 0.65% | $278M | 787,022 | Added |
| Deere & CompanyDE | 0.64% | $273M | 430,735 | Trimmed |
| CMECME | 0.63% | $268M | 1,211,852 | Trimmed |
| Bank of New York MellonBK | 0.58% | $245M | 1,697,438 | Trimmed |
| Intercontinental Exchange | 0.56% | $239M | 1,939,708 | Held |
| EOG ResourcesEOG | 0.51% | $217M | 1,673,501 | Trimmed |
| Merck & CompanyMRK | 0.50% | $214M | 1,664,909 | Trimmed |
| Union PacificUNP | 0.49% | $210M | 772,772 | Added |
| Sherwin-WilliamsSHW | 0.48% | $206M | 597,132 | Trimmed |
| CaterpillarCAT | 0.45% | $191M | 179,790 | Added |
| LindeLIN | 0.43% | $183M | 353,529 | Trimmed |
By sector
Share of the reported value.
Reported value over time
Total 13F value at each quarter end.
Questions
What stocks does Fayez Sarofim own?
In the Q2 2026 13F, Fayez Sarofim & Co reported 300 US stock positions worth $42.5B. The largest: Apple (AAPL) 9.5%, Microsoft (MSFT) 7.3%, Alphabet (GOOG) 6.5%, NVIDIA (NVDA) 4.7%, Amazon.com (AMZN) 4.7%.
What did Fayez Sarofim buy last quarter?
In Q2 2026: new position in AstraZeneca (AZN); new position in TotalEnergies (TTE); new position in Boeing (BA); added to Apple (AAPL); added to Microsoft (MSFT); added to Alphabet (GOOG).
What did Fayez Sarofim sell last quarter?
In Q2 2026: cut Taiwan Semiconductor Manufacturing (TSM); cut Exxon Mobil (XOM); cut Visa (V).
When is Fayez Sarofim's next 13F?
13F filings are due 45 days after each quarter ends. The Q3 2026 filing is due by November 14, 2026.
More investors
13F filings list US-listed long positions (and some options) held at quarter end. They leave out short positions, cash, bonds and non-US holdings, and arrive up to 45 days after the quarter ends, so the investor may have traded since. Information only, not investment advice.